News
European digital health coaching company, Liva Healthcare and global biotechnology organisation, Amgen, have announced a partnership to make cardiac rehabilitation accessible to patients following a heart attack.
The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.
The integration is aimed at boosting data collection.
Watertown, Massachusetts-based Firefly Health has closed its $40 million Series B funding round, led by Andreessen Horowitz.
The new research collaboration will zero in on athletes across Pac-12 universities.
This comes just a week after news broke that Bright Health plans IPO.
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.
The technology release launches the delayed MedTech Funding Mandate that accelerates uptake of innovative treatments and therapies.
The company first collaborated with HSE on a pilot programme for psychological services in 2018.
The partnership aims to produce new educational content for eye care professionals.